Anteris Technologies Ltd logo

Anteris Technologies Ltd(ASX) AVR

Market CapA$222.81MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (2011)-86%
5 Year+17%
1 Year-47%
1 Month+3%
A$9.43
-1.67%
-0.16Today
Anteris Technologies Ltd last closing stock price
MetricPriceDate
Last closeAUD 10.542024-12-05
Anteris Technologies Ltd stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week+6.46%AUD 9.902024-11-28
1 month+3.33%AUD 10.202024-11-05
3 month+5.51%AUD 9.992024-09-06
Year to date-44.96%AUD 19.152023-12-29
1 year-46.77%AUD 19.802023-12-06
3 year+25.48%AUD 8.402021-12-03
5 year+17.11%AUD 9.002019-12-06
Since inception-86.4%AUD 70.232011-06-27

Anteris Technologies Ltd Financials at a Glance

Market Cap

A$222.81MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

$4.51M

Net Income (TTM)

-$180.35M

EPS (TTM)

A$0.00

P/E Ratio

-2.09

Dividend

A$0.00

Beta (Volatility)

-17.05 (Low)

Price

A$9.43

Volume

2,290

Open

A$9.57

Previous Close

A$9.59

Daily Range

A$9.43 - A$9.57

52-Week Range

A$5.20 - A$23.93

Estimated Earnings Date

Aug 17, 2026

AVR News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Anteris Technologies Ltd

Anteris Technologies Ltd is a pioneering company in the structural heart domain, focusing on innovative medical devices. The firm specializes in regenerative tissue technology and is advancing its flagship product, DurAVR™, a 3D single-component aortic valve designed for aortic stenosis treatment.

Products and Services
  • DurAVR™, a 3D aortic valve for aortic stenosis
  • ADAPT, a regenerative tissue technology product
  • Research and development in regenerative medicines
Growth Outlook
  • Recent quarterly revenue increased to AUD 1.5 million
  • Strong gross profit margin of 77% in Q2 2026
  • Significant investment in R&D, exceeding AUD 40 million in Q2 2026
Financial Highlights
  • Cash reserves of AUD 257 million as of June 2026
  • Current ratio of 14.2, indicating strong liquidity
  • Net income loss reduced to AUD 52 million in Q2 2026
Anteris Technologies Ltd operates in the healthcare sector, specifically within the medical devices industry. The company has made significant strides in developing advanced solutions for heart conditions, particularly through its innovative products. The recent quarterly financials indicate a positive trend in revenue growth, alongside a robust gross profit margin, showcasing the potential for future profitability. The substantial investment in research and development reflects the company's commitment to innovation and long-term growth. With a strong liquidity position, Anteris is well-equipped to navigate the challenges of the medical device market. The focus on regenerative technologies positions the company favorably within a growing sector, making it an intriguing option for potential investors.
AI Generated • Sep 21, 2026

Industry

Healthcare Equipment and Supplies

Headquarters

Toowong, QLD 4066, AU

AVR Financials

Key Financial Metrics (TTM)

Gross Margin

72.55%

Operating Margin

-4574.84%

Net Income Margin

-4482.38%

Return on Equity

-99.78%

Return on Capital

-4289.36%

Return on Assets

-46.01%

Earnings Yield

-47.85%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

A$222.81MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

21.14M

Volume

2.29K

Avg. Volume

28.78K

Financials (TTM)

Gross Profit

$2.99M

Operating Income

-$184.69M

EBITDA

-$181.91M

Operating Cash Flow

-$97.36M

Capital Expenditure

-$3.12M

Free Cash Flow

-$100.48M

Cash & ST Invst.

$257.05M

Total Debt

$3.32M

Anteris Technologies Ltd Performance Analysis

Anteris Technologies Ltd sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q42024-12-31-38.6%
Q22025-06-30-69.0%
Q42025-12-31219.8%
Q22026-06-3016.1%
Anteris Technologies Ltd sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q42024-12-3132.0%
Q22025-06-3079.7%
Q42025-12-31-434.2%
Q22026-06-3071.9%

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Currently no data to display.

Quarterly Performance

Name
Q2 2026YOY CHG

Revenue

$1.50M

-29.3%

Gross Profit

$1.16M

+22.0%

Gross Margin

76.91%

N/A

Market Cap

A$222.81MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

A$1.28M

N/A

Employees

174

N/A

Net Income

-$52.16M

-2.6%

EBITDA

-$54.15M

-5.5%

Quarterly Fundamentals

Name
Q2 2026YOY CHG

Total Cash

$257.05M

+2270.4%

Total Debt

$3.32M

+20.3%

Accounts Receivable

$548.40K

-67.1%

Inventory

$8.01K

-98.6%

Long Term Debt

$2.30M

+55.6%

Short Term Debt

$1.03M

-20.1%

Return on Assets

-46.01%

N/A

Return on Invested Capital

-50.35%

N/A

Free Cash Flow

-$50.01M

-11.1%

Operating Cash Flow

-$49.23M

-14.7%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
ARX.AXAroa Biosurgery Limited
A$0.50-1.98%
TTX.AXTetratherix Ltd.
A$6.37-0.62%
PNV.AXPolyNovo Limited
A$0.94-1.05%

Trending Stocks

Symbol / CompanyPricePrice Chg
ONDSOndas
$6.67-0.89%
INTCIntel
$101.35-3.20%
NOKNokia
$9.90-4.44%
NVDANvidia
$226.32-1.29%

Questions About AVR

What is the current price of Anteris Technologies Ltd?

Anteris Technologies Ltd is trading at A$9.43 per share.

What is the 52-week range for Anteris Technologies Ltd?

Over the past 52 weeks, Anteris Technologies Ltd has traded between A$5.20 and A$23.93.

How much debt does Anteris Technologies Ltd have?

Anteris Technologies Ltd total debt is unavailable.

How much cash does Anteris Technologies Ltd have on hand?

Anteris Technologies Ltd does not have cash on hand data available.

What is Anteris Technologies Ltd’s dividend yield?

Anteris Technologies Ltd does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.